Phase I Expansion Study Of Mirvetuximab Soravtansine, A Folate Receptor Alpha (Fra)-Targeting Antibody-Drug Conjugate (Adc), In Patients With Endometrial Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要